Records containing: Lymphoma
This is the wording recorded or indexed by the source. An agency index term is not necessarily an authorised indication. Co-listed drug names are not linked to this term as a treatment relationship.
Follow recorded terms in Drug Alerts for Android. Free includes unlimited local condition follows and an on-open recent-record watchlist. Plus adds no ads and personal organization tools.
All
FDA submission records
EMA medicine records
ClinicalTrials.gov record updates
ClinicalTrials.gov records with results posted
-
CLINICAL_TRIALS study record update · 2026-01-12A Phase I/II, Open-label, Dose-escalation and Expansion Study to Assess the Safety, Pharmacokinetics and Clinical Activity of NUC-7738, a Nucleotide Analogue, in Patients With Advanced Solid Tumours and Lymphoma
-
CLINICAL_TRIALS study record update · 2026-01-12Phase I/II Clinical Study to Evaluate the Safety, Tolerability, Pharmacokinetics, Pharmacodynamics, and Initial Efficacy of XNW5004 Tablets in Patients With Relapsed/Refractory Advanced Tumors
-
CLINICAL_TRIALS study record update · 2026-01-09A Phase II Study of Response Adapted Ultra Low Dose 4 Gy Radiation for Definitive Therapy of Marginal Zone Lymphoma
-
CLINICAL_TRIALS study record update · 2026-01-09Image-guided Lymphadanectomy in AMIGO
-
CLINICAL_TRIALS study record update · 2026-01-08Neurotoxicity Prophylaxis With Intrathecal Dexamethasone and Simvastatin in Adults Receiving Axicabtagene Ciloleucel (Axi-Cel) Treatment
- Organize your saved records without ads with Plus.
-
CLINICAL_TRIALS study record update · 2026-01-07A Communication-Based Intervention for Cancer Patient-Caregiver Dyads to Increase Engagement Treatment Planning and Reduce Caregiver Burden
-
CLINICAL_TRIALS study record update · 2026-01-06LCCC 1229: Developing a Prospective Lymphoma Clinical Cohort in Malawi
-
CLINICAL_TRIALS study record update · 2026-01-06Phase I Study of the Administration of T Lymphocytes Co-Expressing the CD30 Chimeric Antigen Receptor (CAR) and CCR4 for Relapsed/Refractory CD30+ Hodgkin Lymphoma and Cutaneous T-Cell Lymphoma
-
CLINICAL_TRIALS study record update · 2026-01-06Phase Ib/II Study of the Administration of T Lymphocytes Expressing the CD30 Chimeric Antigen Receptor (CAR) for Relapsed/Refractory CD30+ Hodgkin's Lymphoma and CD30+ Non-Hodgkin's Lymphoma
-
CLINICAL_TRIALS study record update · 2026-01-06Immune Reconstitution Monitoring and Pneumococcal Vaccination (PCV-21) in Patients Treated With Chimeric Antigen Receptor T-Cells
-
CLINICAL_TRIALS study record update · 2026-01-05A Multicenter, Open-Label, Dose-Escalation and Dose-Expansion Phase I/II Study of ZG005 in Combination With Gecacitinib in Patients With Relapsed or Refractory Lymphoma
-
CLINICAL_TRIALS study record update · 2026-01-05An Exploratory Clinical Study of the Safety and Efficacy of Allogenic CD19-Targeted Chimeric Antigen Receptor T-Cell Injection in the Treatment of Relapsed/Refractory B-Cell Hematologic Malignancies
-
CLINICAL_TRIALS study record update · 2026-01-02Study of the Angiogenesis Measured by PET/CT With 18F-RGD-K5 in Patients With Lymphoma : a Preliminary Study
-
CLINICAL_TRIALS study record update · 2026-01-02GSL Synthetase Inhibitor Eliglustat Combined With CD30 Target Immunotherapy for the Treatment of of CD30+ Lymphoma: an Open-Label, Randomized, Phase I/II Study
-
CLINICAL_TRIALS study record update · 2025-12-31An Open-Label, Multicenter, Single-Arm, Sequential Phase-2 Study of Mosunetuzumab Alone or With Zanubrutinib for the Treatment of Patients With Newly Diagnosed Follicular Lymphoma in Need of Systemic Therapy
-
CLINICAL_TRIALS study record update · 2025-12-29An i3+3 Phase I Dose-per-Fraction Escalation Trial for Relapsed/Refractory Hodgkin/Non-Hodgkin Lymphoma
-
CLINICAL_TRIALS study record update · 2025-12-26Efficacy and Safety of Reduced-Dose Apixaban and Rivaroxaban Versus Low-Molecular-Weight Heparin in Patients With Hematologic Malignancies: A Prospective Randomized Study
-
CLINICAL_TRIALS study record update · 2025-12-26The Impact of Artificial Intelligence-Assisted Health Education on Patients' Intention to Participate in Clinical Trials: A Cluster-Randomised Controlled Trial
-
CLINICAL_TRIALS study record update · 2025-12-26A Phase 1 Study of LY3039478 in Patients With Advanced or Metastatic Cancer
-
CLINICAL_TRIALS study record update · 2025-12-24Observational, Non-interventional, Multicenter Study Aimed at Collecting Prospective Data Related to Study Safety and Effectiveness in Real Clinical Practice in Patients With CD30+ Lymphoma (BRAVE Study)
-
CLINICAL_TRIALS study record update · 2025-12-23xDRIVE Functional Precision Medicine + Artificial Intelligence Individualized Treatments for Florida-based Cancer Patients With Relapsed/ Refractory Cancers
-
CLINICAL_TRIALS study record update · 2025-12-22PTCy + Sirolimus/VIC-1911 as GVHD Prophylaxis in Myeloablative PBSC Transplantation
-
CLINICAL_TRIALS study record update · 2025-12-18Bone Marrow Grafting for Leukemia and Lymphoma
-
CLINICAL_TRIALS study record update · 2025-12-17A Multicenter, Open-label, Interventional Phase I Trial to Determine the Dose and Evaluate the Pharmacokinetics (PK) and Safety of Lutetium Lu 177 Edotreotide Targeted Radiopharmaceutical Therapy (RPT) as Monotherapy or Following Standard of Care (SoC) for the Treatment of Somatostatin Receptor-positive Tumors in the Pediatric Population (KinLET).
-
CLINICAL_TRIALS study record update · 2025-12-16Shanghai Lymphoma Clinical Cohort